SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1032)3/24/2002 2:01:25 PM
From: Extra Pale  Read Replies (1) of 2243
 
Rick,

I took a look at the LEAPS with the intent of playing devil's advocate. Sorry, I will be buying on Monday -g-. Risk that I see is that ELN significantly misses its forecasted earnings, is taken out back and shot. Under this scenario, a smart pharma acquires ELN in 2003 for something under $20/share. Not sure what probability to assign to this scenario. Basically the risk/reward of LEAPS looks good, IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext